Latest news
SION Stock On Track For Worst Day Ever After 90% Drop — What’s Driving The Selloff? - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 17:18:37 GMTSionna cystic fibrosis drug fails key trial, removing threat to Vertex - BioPharma DiveBioPharma Dive · Mon, 10 Aug 2026 16:27:14 GMTTNX-103 Misses Primary Endpoint in Phase 3 LEVEL PH-HFpEF Trial - HCPLiveHCPLive · Mon, 10 Aug 2026 15:03:24 GMTSionna Shares Tumble After Cystic-Fibrosis Treatment Unexpectedly Misses Endpoint - BitgetBitget · Mon, 10 Aug 2026 14:13:40 GMTSionna Therapeutics shares collapse 92% after cystic fibrosis trial misses key endpoint - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 12:48:07 GMTSionna Scraps Mid-Stage Cystic Fibrosis Drug After Efficacy Miss - streamlinefeed.co.kestreamlinefeed.co.ke · Mon, 10 Aug 2026 12:03:17 GMTSionna reports Phase 2a miss for SION-719, favors SION-451+SION-2222; Q2 cash $268.3M - TradingViewTradingView · Mon, 10 Aug 2026 11:23:01 GMTSionna Won’t Advance Add-On Drug After CF Trial Misses Goal - Stock TitanStock Titan · Mon, 10 Aug 2026 11:00:00 GMT